(Q37741046)

22 August 2017

1 reference

title

Cancer therapies and bone health (English)

1 reference

22 August 2017

Mimi I Hu

1

1 reference

22 August 2017

Huifang Lu

series ordinal

2

1 reference

22 August 2017

Robert F Gagel

series ordinal

3

1 reference

22 August 2017

publication date

1 June 2010

1 reference

Current Rheumatology Reports

22 August 2017

published in

1 reference

22 August 2017

volume

12

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

177-185

1 reference

Reduced bone mineral density in men following chemotherapy for Hodgkin's disease

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-010-0098-X

Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer

21 January 2018

1 reference

12 December 2020

Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status

1 reference

12 December 2020

Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma.

1 reference

12 December 2020

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

1 reference

12 December 2020

Mechanisms of steroid impairment of growth

1 reference

12 December 2020

Adriamycin inhibits PTH-mediated but not PGE2-mediated stimulation of cyclic AMP formation in isolated bone cells

1 reference

12 December 2020

Toxic effects of cis-dichlorodiammineplatinum(II) in man.

1 reference

12 December 2020

Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies

1 reference

12 December 2020

Nephrotoxicity associated with ifosfamide

1 reference

12 December 2020

Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy

1 reference

12 December 2020

National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist

1 reference

12 December 2020

Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience

1 reference

12 December 2020

Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study

1 reference

12 December 2020

Doxorubicin inhibits differentiation and enhances expression of the helix-loop-helix genes Id and mTwi in mouse osteoblastic cells

1 reference

12 December 2020

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

1 reference

12 December 2020

Potential for cancer related health services research using a linked Medicare-tumor registry database.

1 reference

12 December 2020

Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial

1 reference

12 December 2020

Transforming growth factor-beta1 to the bone

1 reference

12 December 2020

A high incidence of vertebral fracture in women with breast cancer

1 reference

12 December 2020

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer

1 reference

12 December 2020

Bone mineralization in women following successful treatment of Hodgkin's disease

1 reference

12 December 2020

Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs

1 reference

12 December 2020

The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancer.

1 reference

12 December 2020

Abnormalities in serum osteocalcin values in children receiving chemotherapy including ifosfamide

1 reference

12 December 2020

Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer

1 reference

12 December 2020

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

1 reference

12 December 2020

Fracture risk following bilateral orchiectomy

1 reference

12 December 2020

Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells

1 reference

12 December 2020

Vitamin D3 and calcium to prevent hip fractures in elderly women

1 reference

12 December 2020

Evaluation of long-term toxicity after chemotherapy for testicular cancer

1 reference

12 December 2020

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Study of histomorphometric changes of the mandibular condyles in neonatal and juvenile rats after administration of cyclophosphamide

1 reference

12 December 2020

Osteoporosis and age-related fracture syndromes.

1 reference

12 December 2020

1 reference

12 December 2020

Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures

1 reference

12 December 2020

Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor

1 reference

12 December 2020

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

1 reference

12 December 2020

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy

1 reference

12 December 2020

Osteoporosis and related risk factors in renal transplant recipients.

1 reference

12 December 2020

Skeletal fractures negatively correlate with overall survival in men with prostate cancer

1 reference

12 December 2020

Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results.

1 reference

12 December 2020

Relative osteopenia after treatment for acute lymphoblastic leukemia

1 reference

12 December 2020

Comparison of the effects of adriamycin and methotrexate on orthotopic and induced heterotopic bone in rats

1 reference

12 December 2020

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer

1 reference

12 December 2020

Skeletal morbidity in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density

1 reference

12 December 2020

Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission

1 reference

12 December 2020

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.

1 reference

12 December 2020

Methotrexate osteopathy in patients with osteosarcoma

1 reference

12 December 2020

Gene expression, cytoskeletal changes and extracellular matrix synthesis in human osteoblasts treated with cyclosporin A.

1 reference

12 December 2020

Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial

1 reference

12 December 2020

Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation

1 reference

12 December 2020

Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long‐term follow‐up of a prospective study

1 reference

12 December 2020

Pamidronate reduces bone loss after allogeneic stem cell transplantation

1 reference

12 December 2020

Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation

1 reference

12 December 2020

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

12 December 2020

Low bone mineral density in hormone-naïve men with prostate carcinoma

1 reference

12 December 2020

NCCN Task Force Report: Bone Health in Cancer Care

1 reference

12 December 2020

Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17

1 reference

12 December 2020

Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model

1 reference

12 December 2020

Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide

1 reference

12 December 2020

Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients

1 reference

12 December 2020

10.1007/S11926-010-0098-X

Identifiers

DOI

1 reference

22 August 2017

1 reference